Study of STA-1 as an Add-on Treatment to Donepezil
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the efficacy and safety of STA-1 vs placebo as an
add-on treatment to donepezil in patients with mild to moderate Alzheimer's Disease (AD).